Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation
The global market for botanical and plant-derived drugs is expected to grow from $38.7 billion in 2025 to $58.1 billion by 2030, at a CAGR of 8.5%
It is not intended for human or veterinary use and is not approved for clinical, diagnostic, or therapeutic applications
Adding the wrong amount does not ruin the peptide
This oxygenating serum boosts hydration, refines pores, and improves skin texture
Our manufacturing process follows GMP standards so researchers can get consistently high quality material for their research
/assets/images/provider/photos/2714075.png)
